miR-185 regulates AQP3 and AQP5 expression, exerting its therapeutic effect by compromising squamous cell carcinoma and colorectal cancer progression [184,185], whereas miR-877 can suppress AQP3 in gastric cancer, promoting apoptosis and reducing cell proliferation, invasion and EMT [186]. Here, AQP5 is linked to colorectal cancer.